New imaging technique captures COVID-19’s impact on the brain
University of WaterlooA University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies how COVID-19 can change the human brain.
A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies how COVID-19 can change the human brain.
Alzheimer’s disease causes changes to the brain that begin two decades or more before symptoms appear. A study by researchers at Washington University School of Medicine in St. Louis reveals that the bacteria that live in the gut also change before Alzheimer’s symptoms arise, a discovery that could lead to diagnostics or treatments for Alzheimer’s disease that target the gut microbiome.
As we enter the summer months in the Northern Hemisphere and the possibility of extreme heat becomes more common, it’s important to stay up-to-date on the science of heat waves and take measures to protect ourselves from this growing public health threat.
Put yourself in the exoskeleton of a bumblebee for a moment: your world would be a riot of colors and scents, both essential to guide your search for pollen and nectar.
University of Queensland researchers have used an algorithm from a video game to gain insights into the behaviour of molecules within live brain cells.
Beta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Hackensack Meridian Health and its Bear’s Den program invest in company to help detect potential health problems hinted in speech patterns
Mitochondria that power cellular activity fragment and change shape in breast cancer cells that migrate to the brain, an adaptation that appears necessary for the cells to survive, UT Southwestern Medical Center researchers report in a new study. The findings, published in Nature Cancer, could lead to new ways to prevent brain metastases, or the spread of cells from primary tumors to the brain.
Women and men who experience migraine headaches also carry an elevated risk of having an ischemic stroke, but women alone may carry an additional risk of heart attack and hemorrhagic stroke, according to a new study led by Cecilia Hvitfeldt Fuglsang of Aarhus University, Denmark publishing June 13th in the open access journal PLOS Medicine.
The Southwest Brain Bank's focus is on neuroscience research related to psychiatric illness. It is a research organization that collects, studies, and distributes donated brain tissue to scientists.
In a pioneering study involving serial entrepreneurs and managers, a multidisciplinary research team led by HEC - School of Management at the University of Liège and Liège University Hospital (CHU Liège), combining entrepreneurship researchers and brain specialists, found evidence of increased neuronal connectivity in the brains of entrepreneurs, which may contribute to distinct cognitive attributes.
A new approach could enhance memory and learning in individuals with Down syndrome by stabilizing a key component in the body's protein sorting system called the retromer complex.
A new study finds temperature affects electrical activity levels in taste bud cells, which could greatly influence perception of taste. The study is published ahead of print in the American Journal of Physiology-Cell Physiology.
Mount Sinai Health System experts will lead key discussions on women’s health, new paths to treat and prevent brain disease, and closing the gap on health disparities at this year’s Aspen Ideas: Health and Aspen Ideas Festival.
Howard Colman, MD, PhD, was recently featured as an author on a publication in Nature Medicine describing the results of a recent clinical trial – a breakthrough in glioblastoma treatment with the help of a modified cold virus injected directly into the tumor. When combined with an immunotherapy drug, the authors observed a subset of patients that appeared to be living longer as a result of this therapy.
The American Academy of Neurology (AAN), the world’s largest association of neurologists and neuroscience professionals, has submitted a Formal National Coverage Determination (NCD) Reconsideration Request to the Centers for Medicare & Medicaid Services (CMS) regarding the existing national coverage determination on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease, including the new therapy lecanemab.
Perhaps the most obvious feature of a neuron is the long branch called an axon that ventures far from the cell body to connect with other neurons or muscles.
Millions of people in the US are concussed every year playing sports. Players of games like American football are at particularly high risk for injuries that can have devastating long-term consequences. Stanford University scientists working with the company Savior Brain have now designed one potential way of protecting players: a helmet containing liquid shock absorbers that could reduce the impact of blows to the head by a third.
A UC Davis MIND Institute researcher is testing a new framework aimed at helping more people with autism and intellectual disabilities find success with employment.
Researchers from The University of Texas at El Paso’s School of Pharmacy will explore the viability of a new treatment for vascular dementia, thanks to a $2.2 million grant from the National Institutes of Health National Institute of Neurological Disorders and Stroke.
Patients suffering from the “most horrible” rare brain tumour are falling through the cracks of mental health provision, University of Essex researchers have found.
An effective treatment for most stroke victims — even those who, today, are unable to gain access to care within the first few hours.
In a new study from Wake Forest University School of Medicine and Atrium Health Levine Cancer Institute, researchers highlight improved outcomes for patients treated with preoperative stereotactic radiosurgery, particularly in rates of tumor recurrence, adverse radiation effects and spread of tumor cells to the fluid outside of the brain.
Researchers at The University of Queensland have discovered viruses such as SARS-CoV-2 can cause brain cells to fuse, initiating malfunctions that lead to chronic neurological symptoms.
Semaglutide is sold under brand names such as Ozempic. Since this medication was also approved for the treatment of obesity, demand has increased, which has resulted in difficulties in procuring the drug in recent times.
People who have insomnia symptoms such as trouble falling asleep, staying asleep and waking up too early, may be more likely to have a stroke, according to a study published in the June 7, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. In addition, researchers found the risk was much higher in people under 50 years old. The study does not prove that insomnia symptoms cause stroke; it only shows an association.
Prior to being diagnosed with epilepsy, 5% of people with a type of epilepsy called focal epilepsy had a seizure while driving, according to a new study published in the June 7, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Matthew Lew, an associate professor of electrical and systems engineering at the McKelvey School of Engineering at Washington University in St. Louis, has received a five-year $2 million Maximizing Investigators’ Research Award (MIRA) from the National Institutes of Health (NIH) to support his ongoing work to improve microscopic imaging techniques.
More than 5,000 people are diagnosed annually with ALS (amyotrophic lateral sclerosis), a fatal, neurodegenerative disease that attacks nerve cells in the brain and spinal cord, gradually robbing people of the ability to speak, move, eat and breathe.
A research consortium, including a Philadelphia College of Osteopathic Medicine neuroscientist and his research coordinator, are calling for a consensus on how scientists identify and evaluate how infections contribute to or cause cognitive impairment and dementias, including Alzheimer’s disease.
Dreams have been considered a hallmark of human sleep for a long time. Latest findings, however, suggest that when pigeons sleep, they might experience visions of flight. Researchers at Ruhr University Bochum, Germany, and at the Max Planck Institute for Biological Intelligence studied brain activation patterns in sleeping pigeons, using functional magnetic resonance imaging.
A team of experimental neurobiologists at Johannes Gutenberg University Mainz (JGU) and theoretical biologists at Humboldt-Universität zu Berlin has managed to solve a mystery that has been baffling scientists for decades. They have been able to determine the nature of the electrical activity in the nervous system of insects that controls their flight. In a paper recently published in Nature, they report on a previously unknown function of electrical synapses employed by fruit flies during flight.
Treatment efficacy for a broad range of chronic diseases does not differ depending on patients’ comorbidities, according to a new study publishing June 6th in the open access journal PLOS Medicine by David McAllister of the University of Glasgow, UK, and colleagues.
Pitt unveils National Sports Brain Bank to track patients with contact-sports backgrounds; Steelers legends Jerome Bettis, Merril Hoge pledge brains and participation in innovative program.
A randomized controlled clinical trial of a device shows promise for quieting the phantom noises of tinnitus.
Researchers at the Beckman Institute for Advanced Science and Technology found that early exposure to an environmental chemical called polychlorinated biphenyls, or PCBs, made it more difficult for mice to recover from sound-related trauma sustained later in life.
Johns Hopkins scientists have developed a method involving artificial intelligence to visualize and track changes in the strength of synapses — the connection points through which nerve cells in the brain communicate — in live animals. The technique, described in Nature Methods, should lead, the scientists say, to a better understanding of how such connections in human brains change with learning, aging, injury and disease.
The pandemic and its aftermath have raised anxiety to new levels. But the roots of anxiety-related conditions, including obsessive-compulsive spectrum disorder (OCSD), are still unclear. In a new study, University of Utah Health scientists discovered insights into the importance of a minor cell type in the brain—microglia—in controlling anxiety-related behaviors in laboratory mice. The findings could lead to new approaches for targeted therapies.
Patients receiving neuromuscular blocking medications as part of their anesthetic regimen should be carefully monitored to ensure the best care and outcomes, according to recent—and independently developed—guidelines from the American Society of Anesthesiologists (ASA) and the European Society of Anaesthesiology and Intensive Care (ESAIC). Today, the organizations published a joint letter in Anesthesiology, ASA’s peer-reviewed medical journal, encouraging widespread implementation of the recommendations in the guidelines.
Sleep medicine experts from the Mount Sinai Health System are presenting new research at SLEEP 2023, the 37th annual meeting of the Associated Professional Sleep Societies running until June 7 in Indianapolis.
Launched this year, the SNS established this new program to increase the pool of neurosurgery residents conducting research and to enhance their success rate in becoming independent neurosurgeon-scientists.
In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening. The finding suggests a possible new treatment option for people with the slow-growing but deadly brain tumor.
Survival rate beyond 10 years in children with drug-resistant epilepsy (DRE) was highest after cranial epilepsy surgery and lowest when treated only with antiseizure medications, according to a study published in The Lancet Child and Adolescent Health. This large, retrospective study was the first to compare long-term survival in children with DRE among cohorts treated with medications only, vagus nerve stimulation plus medications, and cranial epilepsy surgery plus medications. Results show that risk of early death was reduced by over 80 percent after surgery and by 40 percent after vagus nerve stimulation, compared to medication-only treatment.
According to the federal government’s National Institute of Neurological Disorders and Stroke, nearly 3 million people worldwide — with almost a third in the United States — are living with multiple sclerosis (MS), a disabling neurological disease in which the body’s immune system mistakenly attacks nerves feeding information to the central nervous system (the brain and spinal cord). Although rarely fatal, MS can lead to long-term disabilities, and impair movement, muscle control, vision and cognition.